Innovating Works

UNITI

Financiado
Unification of treatments and Interventions for Tinnitus patients
Tinnitus is the perception of a phantom sound and the patient’s reaction to it. Tinnitus remains a scientific and clinical enigma of iTinnitus is the perception of a phantom sound and the patient’s reaction to it. Although much pr... Tinnitus is the perception of a phantom sound and the patient’s reaction to it. Tinnitus remains a scientific and clinical enigma of iTinnitus is the perception of a phantom sound and the patient’s reaction to it. Although much progress has been made, tinnitus remains a scientific and clinical enigma of high prevalence and high economic burden. It affects more than 10% of the general population, whereas 1% of the population considers tinnitus their major health issue. Recent cohort studies show that tinnitus prevalence tends to increase over time and with older age. Assuming that there is no cure to be found, the prevalence estimates in Europe would double by 2050. A large variety of patient characteristics - including genotyping, aetiology, and phenotyping - are poorly understood, because integrated systems approaches are still missing to correlate patient`s characteristics to predict responses to combinatorial therapies. Although genetic causes of tinnitus have been neglected for decades, recent findings of genetic analysis in specific subgroups (gender and phenotype) have highlighted that bilateral tinnitus in men reached a heritability of 0.68. This heritability is close to autism, schizophrenia and Attention Deficit Hyperactive Disorder (ADHD). There is no current consensus on tinnitus treatment. UNITI’s overall aim is to deliver a predictive computational model based on existing and longitudinal data attempting to address the question which treatment approach is optimal for a specific patient based on specific parameters. Clinical, epidemiological, medical, genetic and audiological data, including signals reflecting ear-brain communication, will be analysed from existing databases. Predictive factors for different patient groups will be extracted and their prognostic relevance will be tested in a randomized controlled trial (RCT) in which different groups of patients will undergo a combination of therapies targeting the auditory and central nervous systems. ver más
30/09/2023
KLINIKUM DER UNIVE...
6M€
Duración del proyecto: 46 meses Fecha Inicio: 2019-11-24
Fecha Fin: 2023-09-30

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2023-09-30
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders
Cerrada hace 6 años
Presupuesto El presupuesto total del proyecto asciende a 6M€
Líder del proyecto
KLINIKUM DER UNIVERSITAET REGENSBURG No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5